Hou et al. found that the clinical pregnancy rate was increased by 92.5% in adenomyosis patients who underwent an ultra-long protocol of GnRH agonists versus a long protocol (OR: 1.925; 95% CI: 1.137–3.250; p:0.015) [6]. Here, GNRH1 is linked to adenomyosis.